---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-033873"
form_type: "8-K/A"
ticker: "TVGN"
cik: "0001860871"
company_name: "Tevogen Bio Holdings Inc."
filed_at: "2024-08-26T23:59:59+00:00"
generated_at: "2026-05-31T07:43:25.182885+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Tevogen Bio raises $6M via Series C Preferred Stock; two closings Aug 30 & Sept 16

## Summary
- Investor to purchase 600 shares of Series C Preferred Stock for $6.0 million aggregate.
- First closing of $4.0M on Aug 30, 2024; second closing of $2.0M on Sept 16, 2024.
- Conversion price: VWAP over 30 trading days prior to conversion, floor $0.6172; subject to 9.99% beneficial ownership limit.
- Preferred stock carries 7.5% annual cumulative dividend, payable in kind or cash, starting Sept 30, 2024.
- Company has call right after five years; stock is non-voting.

## SEC filing metadata
- accession: 0001493152-24-033873
- form_type: 8-K/A
- ticker: TVGN
- cik: 0001860871
- company_name: Tevogen Bio Holdings Inc.
- filed_at: 2024-08-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860871/000149315224033873/0001493152-24-033873-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860871/000149315224033873/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-033873
- JSON: https://secwatch.observer/filing/0001493152-24-033873.json
- Plain text: https://secwatch.observer/filing/0001493152-24-033873.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.